v3.26.1
Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Warrant Activity The following is a summary of the Company’s warrants as of March 31, 2026:
Number of Warrants
Equity
 classified
Liability classifiedTotalWeighted-average
exercise price
Outstanding at March 31, 20266,560 685,712 692,272 $46.76 
Schedule of Authorized Shares of Common Stock for Future Issuance
The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:
 March 31, 2026
Exercise of warrants692,272 
Shares available for future stock incentive awards3,641,284 
Unvested restricted stock units736,272 
Outstanding common stock options3,542,407 
Series A Preferred Stock4,026,346 
Series B Preferred Stock437,927 
Total13,076,508